Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OTO-413
- Development stage
- Phase 2
- Lead developer
- Otonomy
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Intratympanic
01
Overview
OTO-413 is a proprietary, sustained-exposure formulation of brain-derived neurotrophic factor (BDNF), a naturally occurring protein involved in neuron growth and repair. It is designed for local administration to the inner ear via intratympanic injection. The drug aims to repair synaptic connections between inner hair cells and auditory nerve fibers in the cochlea that are damaged due to noise trauma or ototoxic chemicals. Preclinical studies have shown that BDNF can restore these connections, which is associated with improved hearing function. Clinical trials have demonstrated that OTO-413 is well-tolerated and may improve speech-in-noise hearing performance in patients with sensorineural hearing loss.
- Other names
- brain derived neurotrophic factorBDNFabrineurin
02
Targets
NTRK2 (Tropomyosin-related kinase receptor type B)NGFR (p75NTR)
Beyond the preview
Go deeper on OTO-413.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTO-413.